Clinical Trials Logo

Clinical Trial Summary

This is a prospective, controlled, randomized, multi-center clinical study of up to 80 subjects with full thickness surgical incisions. Each incision included in the study will be segmented into two halves; each half will be randomized to receive final skin closure with either Prineo (DERMABOND PROTAPE) or intradermal sutures. Subjects will be evaluated post-operatively at 24 hours (± 6 hours), 7 days (± 1 day), 12 - 25 days, and 90 days (± 10 days).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00557947
Study type Interventional
Source Ethicon, Inc.
Contact
Status Completed
Phase Phase 4
Start date August 2007
Completion date April 2009

See also
  Status Clinical Trial Phase
Completed NCT03020420 - Clinical Trial To Study The Anti-scarring Effect Of Cicatricell N/A
Withdrawn NCT00872638 - The Effect of Wound Edge Eversion on Cosmesis N/A
Completed NCT01835405 - LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds N/A
Completed NCT00890578 - HISTOACRYL: A Study of Its Efficacy in Final Scar Formation Phase 4